CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ (20,765)	$ 256,631
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization of real estate, in-place lease, and other intangibles	796,779	782,736
Stock-based compensation amortization expense	10,410	11,935
Merger-related post-combination stock compensation expense	0	16,223
Amortization of deferred financing costs and debt discounts (premiums)	23,708	19,247
Straight-line rents	(30,836)	(32,891)
Amortization of non-refundable entrance fees and above (below) market lease intangibles	(100,215)	(88,925)
Equity loss (income) from unconsolidated joint ventures	176,691	1,407
Distributions of earnings from unconsolidated joint ventures	16,861	11,228
Deferred income tax expense (benefit)	(131)	11,156
Impairments and loan loss reserves (recoveries), net	(117)	11,346
Loss (gain) on sales of real estate, net	(13,136)	(187,624)
Loss (gain) upon change of control, net	0	(77,548)
Casualty-related loss (recoveries), net	9,825	(574)
Other non-cash items	(7,826)	(1,652)
Changes in:
Decrease (increase) in accounts receivable and other assets, net	9,756	2,071
Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue	86,871	52,200
Net cash provided by (used in) operating activities	957,875	786,966
Cash flows from investing activities:
Acquisitions of real estate	(43,880)	(4,466)
Development, redevelopment, and other major improvements of real estate	(547,087)	(399,373)
Leasing costs, tenant improvements, and recurring capital expenditures	(76,125)	(76,744)
Proceeds from sales of real estate, net	30,839	619,981
Proceeds from the Callan Ridge JV transaction, net	0	125,662
Investments in unconsolidated joint ventures	(76,329)	(54,450)
Distributions in excess of earnings from unconsolidated joint ventures	22,745	20,195
Proceeds from insurance recovery	12,214	6,467
Proceeds from sales/principal repayments on loans receivable and other	125,927	87,259
Investments in loans receivable and other	(77,357)	(25,341)
Cash paid in connection with the Merger, net	0	(179,215)
Net cash provided by (used in) investing activities	(629,053)	119,975
Cash flows from financing activities:
Borrowings under bank line of credit and commercial paper	9,435,650	3,146,250
Repayments under bank line of credit and commercial paper	(9,217,525)	(3,866,250)
Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt	987,260	750,000
Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt	(806,492)	(3,038)
Payments for deferred financing costs	(2,604)	(5,438)
Issuance of common stock and exercise of options, net of offering costs	304	241
Repurchase of common stock	(97,058)	(190,364)
Dividends paid on common stock	(637,234)	(584,964)
Distributions to and purchase of noncontrolling interests	(28,820)	(80,368)
Contributions from and issuance of noncontrolling interests	13,124	12
Net cash provided by (used in) financing activities	(353,395)	(833,919)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(24,573)	73,022
Cash, cash equivalents, and restricted cash, beginning of period	184,305	169,023
Cash, cash equivalents, and restricted cash, end of period	$ 159,732	$ 242,045